EP1480995A4 - Inhibiteurs de cks1 - Google Patents
Inhibiteurs de cks1Info
- Publication number
- EP1480995A4 EP1480995A4 EP03711050A EP03711050A EP1480995A4 EP 1480995 A4 EP1480995 A4 EP 1480995A4 EP 03711050 A EP03711050 A EP 03711050A EP 03711050 A EP03711050 A EP 03711050A EP 1480995 A4 EP1480995 A4 EP 1480995A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cks1
- inhibitors
- cks1 inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35690602P | 2002-02-12 | 2002-02-12 | |
US356906P | 2002-02-12 | ||
PCT/US2003/004550 WO2003068939A2 (fr) | 2002-02-12 | 2003-02-12 | Inhibiteurs de cks1 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1480995A2 EP1480995A2 (fr) | 2004-12-01 |
EP1480995A4 true EP1480995A4 (fr) | 2006-09-13 |
Family
ID=27734702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03711050A Withdrawn EP1480995A4 (fr) | 2002-02-12 | 2003-02-12 | Inhibiteurs de cks1 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1480995A4 (fr) |
JP (1) | JP2005523280A (fr) |
AU (1) | AU2003215235A1 (fr) |
CA (1) | CA2474844A1 (fr) |
WO (1) | WO2003068939A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2954896A1 (fr) * | 2014-06-13 | 2015-12-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibiteurs à petite molécule de la ligase de Skp2 E3 dans la dépression et d'autres maladies |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997011176A2 (fr) * | 1995-09-21 | 1997-03-27 | Cold Spring Harbor Laboratory | Proteines associees a cycline kinases dependantes de la cycline ckd, et utilisations qui y sont liees |
WO2002055665A2 (fr) * | 2001-01-05 | 2002-07-18 | Univ New York | Procedes destines a identifier des composes utiles dans le traitement de troubles de proliferation et de differenciation |
WO2002068444A1 (fr) * | 2001-02-21 | 2002-09-06 | Chiron Corporation | Utilisation de la ttk à des fins de diagnostic et comme cible thérapeutique du cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801015A (en) * | 1995-06-05 | 1998-09-01 | Mitotix, Inc. | Nucleic acid encoding a Candida cell cycle regulatory protein, TYP1 polypeptide |
CA2284136C (fr) * | 1997-03-14 | 2009-02-10 | Cropdesign N.V. | Procede et moyens de modulation des proteines du cycle cellulaire des plantes et utilisation de ces moyens pour controler la croissance cellulaire des plantes |
US6573094B1 (en) * | 1997-10-16 | 2003-06-03 | Baylor College Of Medicine | F-box genes and proteins |
-
2003
- 2003-02-12 AU AU2003215235A patent/AU2003215235A1/en not_active Abandoned
- 2003-02-12 JP JP2003568054A patent/JP2005523280A/ja active Pending
- 2003-02-12 CA CA002474844A patent/CA2474844A1/fr not_active Abandoned
- 2003-02-12 WO PCT/US2003/004550 patent/WO2003068939A2/fr active Application Filing
- 2003-02-12 EP EP03711050A patent/EP1480995A4/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997011176A2 (fr) * | 1995-09-21 | 1997-03-27 | Cold Spring Harbor Laboratory | Proteines associees a cycline kinases dependantes de la cycline ckd, et utilisations qui y sont liees |
WO2002055665A2 (fr) * | 2001-01-05 | 2002-07-18 | Univ New York | Procedes destines a identifier des composes utiles dans le traitement de troubles de proliferation et de differenciation |
WO2002068444A1 (fr) * | 2001-02-21 | 2002-09-06 | Chiron Corporation | Utilisation de la ttk à des fins de diagnostic et comme cible thérapeutique du cancer |
Non-Patent Citations (2)
Title |
---|
SMITH J P ET AL: "Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer", CANCER LETTERS, NEW YORK, NY, US, vol. 135, no. 1, 8 January 1999 (1999-01-08), pages 107 - 112, XP002357825, ISSN: 0304-3835 * |
WADE HARPER J: "Protein destruction: Adapting roles for Cks proteins", CURRENT BIOLOGY, vol. 11, no. 11, 2001, pages R432 - R435, XP002391696 * |
Also Published As
Publication number | Publication date |
---|---|
EP1480995A2 (fr) | 2004-12-01 |
AU2003215235A1 (en) | 2003-09-04 |
JP2005523280A (ja) | 2005-08-04 |
WO2003068939A3 (fr) | 2003-12-31 |
CA2474844A1 (fr) | 2003-08-21 |
AU2003215235A8 (en) | 2003-09-04 |
WO2003068939A2 (fr) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25482A (en) | Inhibitors | |
AU2003202263A1 (en) | Roh-kinase inhibitors | |
PL373146A1 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
AU2003249738A8 (en) | Ostoscope | |
AU2003297193A8 (en) | Meta-web | |
HK1077762A1 (zh) | TFGß[轉化生長因子]的抑制劑 | |
AU2003300832A8 (en) | Nf-kappab inhibitors | |
EP1472536A4 (fr) | Inhibiteurs polyvalents | |
AU2003252028A8 (en) | Heterodiamondoids | |
EP1532133A4 (fr) | Inhibiteurs de nf-:b | |
GB0219961D0 (en) | Oxytocin inhibitors | |
IL165475A0 (en) | Nitrooxyderivatives of eyclooxygenase-2 inhibitors | |
AU2003279495A8 (en) | Alert-modeling | |
IL164898A0 (en) | Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors | |
EP1541580A4 (fr) | Inhibiteurs de sulfotransferase | |
AU2003224941A8 (en) | Nf-kappab inhibitors | |
AU2003264900A8 (en) | Cast-cutter | |
AU2002367810A8 (en) | Bis-transition-metal-chelate-probes | |
AU2003262681A8 (en) | Hemo-aide | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
AU2003215235A8 (en) | Cks1 inhibitors | |
AU2002341221A8 (en) | Honey-brandy | |
AU2003253735A8 (en) | Vacuolins | |
GB0226149D0 (en) | Inhibitors | |
GB0224102D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040907 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 35/00 20060101ALI20060727BHEP Ipc: A61K 48/00 20060101ALI20060727BHEP Ipc: C07H 21/02 20060101ALI20060727BHEP Ipc: C07H 21/04 20060101AFI20040915BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060810 |
|
17Q | First examination report despatched |
Effective date: 20061205 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091215 |